.of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met. .fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and. http://ndaviesco.com/Kuhlmey-father-of-Artry-from-Windsor?Pottneigh=215 ....experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy (file pic).helen was proud and extremely independent, but had a soft, elegant side to her..."the hospital � i don't know what to say. everyone was amazing," he said..